In the Phase 2 IZALCO study, we evaluated efficacy, patient preference, safety and pharmacokinetics for isatuximab administered SC by an innovative on-body injector (OBI) or manual injection, plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results